All articles by Anne-Charlotte Ackermann

Anne-Charlotte Ackermann

Brukinsa: launch sequence of first Chinese cancer drug to roll out internationally

Two years after it received US FDA approval, BeiGene’s Brukinsa (zanubrutinib) has made steady progress around the world.

2021: a record year for orphan therapies

In this blog, the Poli team looks back at the 2021 pricing and reimbursement trends in the orphan drug space in 7 countries: Europe-5 (France, Germany, Italy, Spain and the UK), Japan and the US.